Vilin Bio Med Limited — Board Meeting, 17-05-2025: Outcome of Board Meeting

Vilin Bio Med Limited has announced a board meeting on approving financial results for the half-year and year ended March 31, 2025. The company reported revenue of ₹15.28 Cr and a profit before tax of ₹0.31 Cr, turning around from a loss last year. Profit after tax was ₹0.22 Cr. Operating costs remained high, driven mainly by material expenses. Cash from operations slipped into negative territory at ₹(3.83) Cr, with cash reserves dropping sharply to ₹0.06 Cr. The company completed its IPO proceeds deployment as planned, with no dividends or new fundraising announced.